Metabolic
Peptides studied for weight management, appetite regulation, and glucose control.
MetabolicTirzepatide
Dual GIP/GLP-1 receptor agonist studied for weight management and glucose control.
MetabolicSemaglutide
GLP-1 receptor agonist researched for appetite regulation and metabolic health.
MetabolicRetatrutide
Triple-receptor agonist explored for next-generation weight management research.
MetabolicAICAR
AICAR is one of the most used laboratory activators of AMPK, and that identity is well documented in a systematic review. Disease model evidence,...
MetabolicSS-31
SS-31 and Forzinity: the U.S. accelerated approval is specific to muscle strength in Barth syndrome. Read the population, endpoint and confirmation limits.
Metabolic5-Amino-1MQ
5-Amino-1MQ is a small molecule NNMT inhibitor, not a peptide, although it is sold alongside peptides. The verified evidence is preclinical:...
MetabolicTesofensine
Tesofensine has randomized human trials showing weight loss, having started as a candidate for neurodegenerative disease. It is a triple monoamine...
MetabolicLiraglutide
Liraglutide is a licensed medicine with substantial randomized evidence: dedicated obesity trials at the higher dose, and pooled analyses showing...
MetabolicDulaglutide
Dulaglutide is a licensed weekly medicine with randomized evidence for glycaemic control and, through pooled class analyses, reduced...
MetabolicCagrilintide
Cagrilintide has randomized human trials, both alone and combined with semaglutide, showing meaningful weight loss in people with overweight or...
MetabolicExenatide
Exenatide was the first licensed GLP-1 receptor agonist, developed from exendin-4 found in Gila monster venom. Randomized comparative trials show...
MetabolicSurvodutide
Survodutide has randomized phase 2 evidence in both obesity and metabolic dysfunction associated steatohepatitis, with dose-dependent effects on...
MetabolicMazdutide
Mazdutide has randomized trials spanning early phase through later studies, conducted largely in Chinese populations, showing weight loss and...
MetabolicAdipotide
Adipotide is a prohibitin-targeting peptidomimetic that produced weight loss in animal studies, including primates. It never progressed to human...
MetabolicSetmelanotide
Setmelanotide is a licensed medicine for rare genetic obesity syndromes, with pooled trial evidence and guideline coverage in Bardet-Biedl...
MetabolicHGH Fragment 176-191
The verified literature for this fragment is thin and old: a 1978 animal study of C-terminal growth hormone fragments that reported effects on...